Skip to main content

Animations

MJFF Publications

4481 - 4490 of 6420 Results
Title
Year
  • Year
  • 2018
  • 2017
  • 2022
  • 2014
  • 2020
  • 2016
  • 2016
  • 2019
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: Tau immunoreactivity in peripheral tissues of human aging and select tauopathies
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2018.12.031
    Citation Count: 49
  • Summary Details
    OPEN
    Title: O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-017-0311-1
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina
    Journal Name: Journal of Extracellular Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jex2.59
    Best OA location URL: https://doi.org/10.1002/jex2.59
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.047
    Citation Count: 22
  • Summary Details
    OPEN
    Title: The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28354
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01780
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1096/fj.201600756r
    Citation Count: 345
  • Summary Details
    OPEN
    Title: Deep Learning With EEG Spectrograms in Rapid Eye Movement Behavior Disorder
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2019.00806
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-019-0164-x
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.aaz9360
    Citation Count: 310
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.